Synta Pharmaceuticals Corp (NASDAQ:SNTA)

2.40
Delayed Data
As of Feb 27
 -0.02 / -0.83%
Today’s Change
2.18
Today|||52-Week Range
6.64
-9.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues14.8M7.6M0.000.00
 
 
 
Depreciation And Amortization1.9M1.5M738.0K516.0K
 
 
 
 
 
 
Operating ExpensesGross Income12.9M6.1M----
 
 
 
General Expenses49.8M51.6M60.4M87.0M
 
 
 
 
 
Research And Development40.3M41.5M49.4M71.9M
 
 
 
 
 
Total Operating Expenses51.7M53.0M61.1M87.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-36.9M-45.4M-61.1M-87.6M
 
 
 
 
 
Interest Expense On Debt569.0K1.9M1.8M2.6M
 
 
 
 
 
Other Expenses0.000.00147.0K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-37.5M-47.4M-62.8M-90.2M
 
 
 
 
 
Net Income-37.5M-47.4M-62.8M-90.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS40.4M47.2M59.4M71.0M
 
 
 
 
 
Shares To Calculate EPS Diluted40.4M47.2M59.4M71.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.93-$1.00-$1.06-$1.27
 
 
 
 
 
EPS Diluted-$0.93-$1.00-$1.06-$1.27
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account